Annual Drug Patent Expirations for GALAFOLD
Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. It is available from one supplier. There are fifty-seven patents protecting this drug.
Drug patent litigation for GALAFOLD.
This drug has one hundred and eigthy-eight patent family members in twenty-eight countries.
The generic ingredient in GALAFOLD is migalastat hydrochloride. One supplier is listed for this compound. Additional details are available on the migalastat hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
